Expert Directory
Professor of medicine at Georgetown University Medical Center. A member of the Institute of Medicine, Goodman is trained in infectious diseases and public health. He formerly served as the U.S. Food and Drug Administration Chief Scientist and Deputy Commissioner. He worked extensively on emerging infectious diseases at FDA and with the U.S. Department of Health and Human Services and has served as an advisor to the World Health Organization and others on medical countermeasures and vaccines. Goodman is director of the Center on Medical Product Access, Safety and Stewardship (COMPASS) at Georgetown and a clinician at MedStar Georgetown University Hospital, the Washington D.C. VA Medical Center and Walter Reed National Military Medical Center.
Sport, Sport In Society, Sport culture, Sport and politics, Sport and media
Stephen Mosher is a professor of sport management and media. Mosher has coached youth sports himself for over 25 years and studies the issues of sport in popular culture. He is currently working on an ethnography of bowling, which discusses how that sport plays a central role in the civic engagement of blue collars workers. In 2001, he wrote a series of columns for ESPN.com on the Little League World Series scandal involving pitcher Danny Almonte, who played despite being two years over the age limit.
---
Associate research professor with the department of microbiology and a member of the Center for Global Health Science and Security at Georgetown University Medical Center. She focuses on research and tools to strengthen global capacities for public health preparedness and response. She has also worked on issues related to medical emergency preparedness, and the consequences of biological, chemical, and radiological exposures during military service. Fisher is a microbiologist by training and an expert in infectious diseases.
---
Global and Infectious Diseases Fellow at the O’Neill Institute. Prior to joining the O’Neill Institute, Tom worked as an epidemiologist, focusing on infectious diseases such as HIV, Lassa, and Ebola. His work has taken him to Sierra Leone and Uganda, where he organized and trained African public health professionals on field epidemiology, Lassa, and other viral hemorrhagic fevers. Vincent can discuss infectious disease epidemiology and global public health.
---
Director of the Center for Global Health Science and Security at Georgetown University Medical Center. For more than a decade, Katz has worked to help design systems and implement policies to facilitate a coordinated response to potential microbial outbreaks and pandemics in 22 countries — many low-resourced and developing. She is an expert on the World Health Organization an its International Health Regulations, and can comment on the international response to situtions like Ebola.
---
Assistant research professor in the Center for Global Health Science and Security. She can address the importance of global frameworks supporting health systems strengthening for public health emergency preparedness and response, and particularly those focused on preventing infectious disease outbreaks. In the context of Ebola, she can speak to her professional experience of supporting public health capacity building during and immediately after the West Africa outbreak (Guinea) and the importance of communication and coordination among multisectoral partners on a national, regional and global level.
---
Faculty director of the O’Neill Institute for National and Global Health Law at Georgetown Law. He is professor of medicine at Georgetown University School of Medicine and professor of public health at the Johns Hopkins University. Gostin is a co-director of the World Health Organization Collaborating Center on National and Global Health Law and has served on numerous WHO expert advisory committees related to public health and global health security. Gostin serves on the Independent Panel on the Global Response to Ebola (Harvard University/London School of Hygiene and Tropical Medicine) and served on the National Academy of Medicine’s Commission on a Global Health Risk Framework for the Future.
Executive director of the O’Neill Institute for National and Global Health Law and a visiting professor of Law at Georgetown Law. He is a co-director of the World Health Organization Collaborating Center on National and Global Health Law. Cabrera has worked on projects with the World Health Organization, the Centers for Disease Control and Prevention, and the Campaign for Tobacco Free Kids, among other organizations. He has studied and is interested in various health law-related fields, such as public health law, sexual and reproductive rights, health and human rights, global tobacco litigation and health systems law and policy. Cabrera can comment in English or Spanish on the actions of the WHO and International Health Regulations related to Ebola.
---
Senior advisor for global health to Georgetown University President John J DeGioia; senior fellow, McCourt School of Public Policy; and senior scholar, O’Neill Institute for National and Global Health Law. Monahan served as the special advisor for Global Health Partnerships at the US Department of State (2010-2014) as well as a counselor to the secretary and director of global health affairs at the U.S. Department of Health and Human Services (2009-2010). While at HHS, Monahan served as the U.S. Government’s primary contact with the leadership of the World Health Organization during the 2009 H1N1 pandemic and helped coordinate the U.S.-led diplomatic strategy to secure commitments from developed countries for donating influenza vaccines to low-income countries. Monahan can discuss the obligation of WHO and member states to support and respond to disease outbreaks.
Vaccines, Infectious Disease, SARS COV-2, covid, HIV, B Cells, T Cells, Antibodies, Viruses, Influenza, Pandemic, Immune System, Immunology, Health, Medicine
Shane Crotty, Ph.D., and his team study immunity against infectious diseases. They investigate how the immune system remembers infections and vaccines. By remembering infections and vaccines, the body is protected from becoming infected in the future. Vaccines are one of the most cost-effective medical treatments in modern civilization and are responsible for saving millions of lives. Yet, good vaccines are very difficult to design, and very few new vaccines have been made in the past 10 years. A better understanding of immune memory will facilitate the ability to make new vaccines. Dr. Tony Fauci, NIH, referred to some of the Crotty lab work as “exceedingly important to the field of immunogen design.”
Dr. Crotty is a member of the LJI Coronavirus Task Force. The Crotty Lab, in close collaboration with the lab of LJI Professor Alessandro Sette, Dr. Biol. Sci., was the first to publish a detailed analysis of the immune system’s response to SARS-CoV-2, the virus that causes COVID-19 (Cell, May 2020). The made a number of important findings. Most importantly, it showed that the immune system activates all three major branches of “adaptive immunity” (which learns to recognize specific viruses) to try to fight the virus: CD4 “helper” T cells , CD8 “killer” T cells, and antibodies. The LJI team found good immune responses to multiple different parts of SARS-CoV-2 (imagine the virus is made out of legos, and the immune system can recognize different individual legos), including the Spike protein, which is the main target of almost all COVID-19 vaccine efforts.
Dr. Crotty has a major focus studying human immune responses to vaccines. His lab is hard at work on candidate HIV vaccines with the CHAVID consortium. His lab is also hard at work on vaccine strategies for influenza, strep throat, and COVID-19. The Crotty lab studies new vaccine ideas and strategies that may be applicable to many diseases, based on a fundamental understanding of the underlying immune responses, and how the cells of the immune system interact.
Dr. Crotty regularly does media outreach on vaccines and immunity to infectious diseases. Dr. Crotty is also the author of Ahead of the Curve, a biography of Nobel laureate scientist David Baltimore, published in 2001, and reviewed in The Wall Street Journal and other publications. He earned his B.S. in Biology and Writing from Massachusetts Institute of Technology (MIT) in 1996, and his Ph.D. in Molecular Biology/Virology from the University of California, San Francisco (UCSF) in 2001.
John Ryan, MD, FACC, FAHA
Dir of Univ of Utah Pulmonary Hypertension Center
University of Utah HealthHeart Failure, Heart Transplant, Hypertension
John Ryan MD, FACC, FAHA, is board certified in Internal Medicine, Cardiovascular Medicine, Advanced Heart Failure and Transplant Cardiology, Echocardiography and Nuclear Cardiology with extensive training and experience in research investigation and clinical patient care. He is an internationally renowned specialist in pulmonary hypertension and the director of the University of Utah Pulmonary Hypertension Center, which is the first accredited Pulmonary Hypertension Association Comprehensive Care Center in the Mountain West. Dr. Ryan is also Sports Cardiology Consultant for the United States Olympic Committee, the National Basketball Association, the Utah Jazz and the University of Utah Utes. Dr. Ryan’s research has been published in leading cardiovascular journals including Circulation, CHEST, The Journal of the American College of Cardiology, among others.
English, Religion, Poverty, Education, Separation of church and state in American public education
Jill Heinrich is a Professor of Education. She taught high school English for eleven years, and her research interests include religious literacy and separation of church and state in American public education, masculinity studies, comparative education in Belize, and poverty and education. Heinrich teaches an off-campus course in San Pedro Town on the island of Ambergris Caye in the country of Belize. Academic History PhD in English Education, University of Iowa, 2001 MS in Secondary School Administration, University of Iowa, 2000 MS in English, Illinois State University, 1989 BA in English, Northern Illinois University, 1985
Cancer, Bone Marrow Transplant, Neoplasm, Neoplasms, luekemia, tissue donation, Pathology
Mark is the Queen's Lead of the £5M Medical Research Council-Cancer Research UK funded Stratified Medicine in Colorectal Cancer Consortium (S:CORT), a UK-wide consortium investigating novel precision medicine approaches in colorectal cancer(CRC). His international reputation in CRC was instrumental in his leading a Critical Gaps in Colorectal Cancer Research Initiative, recently published in the high impact factor journal Gut; this landmark publication has attracted significant global attention (his podcast had the most “hits” of any article in the journal) Mark is Queen's Lead of the Health Data Research UK Substantive Site, one of only 6 in the UK, which aims to drive innovative precision medicine and public health approaches through the use of Big Data. He is also national lead for Cancer Strategy for HDR-UK. Mark was co-chair of the Cancer Task Team of the Clinical Working Group of the Global Alliance for Genomics and Health (GA4GH), an international cooperative dedicated to effective and responsible sharing of genomic and clinical data. He has authored a number of key papers including a blueprint for cancer date sharing (published in Nature Medicine) and a road map/call to action for a Global Cancer Knowledge Network in the New England Journal of Medicine Mark has published over 180 papers in international peer review journals, including key papers in the highest impact journals (New Engl J Medicine, Lancet, Nature Medicine, Lancet Oncology, Cancer Discovery, Nature Comms, Gut etc). He is co-lead of an ambitious proposal to develop a Global Innovation Institute in Belfast which will include the One Health Innovation Centre (OHIC), the world’s first Health and Agri-Food Informatics Innovation Centre. Mark’s work has been recognised by a number of national/international awards including the Vander Molen Prize for Leukaemia Research, the Ely Lilly Prize, the St Lukes Medal for Cancer Research and the Graves Medal for Medical Research. He is frequently invited as a guest speaker to international conferences and sits on a number of high level boards/committees at European level including the European Alliance for Personalised Medicine, the Scientific Board of the European Cancer Patient Coalition and the European Cancer Organisation (ECCO) Oncopolicy Forum Mark has a strong commitment to patient-centred research/care and to addressing cancer inequalities. He was the architect of the European Cancer Patient's Bill of Rights (BoR), a catalyst for change and empowerment tool for cancer patients which he launched in the European Parliament on World Cancer Day 2014. The BoR has been adopted across Europe and led to the 70:35 Vision, 70% survival for all cancer patients in Europe by 2035 which was recently adopted by ECCO, the largest interdisciplinary cancer organisation in Europe. Mark’s advocacy work was instrumental in the recent decision to include boys in national UK HPV vaccination programmes. He is also committed to the provision of optimal pathology and laboratory medicine for citizens in resource-limited settings and was senior author of a recent paper in The Lancet as part of The Lancet Series on Pathology and Laboratory Medicine in Low- and Middle- Income Countries.
Brexit, Ireland, EU, Peace Process, Northern Ireland, borders research, conflict analysis, Conflict, post-conflict
Dr Katy Hayward is one of the leading political sociologists on the island of Ireland, and is a Reader in Sociology, and Senior Research Fellow at the Senator George J. Mitchell Institute for Global Peace, Security and Justice at Queen’s University Belfast. Dr Hayward’s research focuses on conflict/post-conflict transitions and is actively interdisciplinary, traversing fields of border studies, conflict studies, European studies, and Irish studies. This means that she is particularly well-placed to speak about the implications of Brexit for the island of Ireland, and Northern Ireland in particular, European integration, political violence, and the application of discourse analysis.
Matthew Davis, MD, MAPP
Population Health Expert
Ann and Robert H. Lurie Children's Hospital of ChicagoChild Health, Population Health, Child Health Policy, Medicaid, Vaccines, Lead Poisoning, Violence
Matthew Davis, MD, MAPP, is Division Head of Academic General Pediatrics and Primary Care at Ann & Robert H. Lurie Children’s Hospital of Chicago and Associate Chief Research Officer for Health Services and Policy Research at Stanley Manne Children's Research Institute at Lurie Children’s. He is a Professor of Pediatrics at Northwestern University Feinberg School of Medicine. His research focus is on population health, with particular emphasis on the family context and impact of local, state and federal policies on child and family health. Before coming to Lurie Children’s, Dr. Davis was at C.S. Mott Children’s Hospital in Michigan, where he was quoted often in the media as the expert on the impact of the Flint, Michigan water contamination crisis.
Food Allergy, Food Allergies, Asthma
Ruchi Gupta, MD, is an Attending Physician, Academic General Pediatrics and Primary Care, at Ann & Robert H. Lurie Children’s Hospital of Chicago and an Associate Professor of Pediatrics at Northwestern University Feinberg School of Medicine. Dr. Gupta also is the Director of the Science and Outcomes of Allergy and Asthma Research Team (SOAAR). Her clinical interests are in the areas of asthma, food allergy, and eczema. She is involved in clinical, epidemiological, and community research. She has been nationally recognized for her research in the areas of food allergy and asthma epidemiology.
Robert Garofalo, MD, MPH
Adolescent Medicine Expert
Ann and Robert H. Lurie Children's Hospital of ChicagoLgbt, transgender children, Adolescent Medicine, Sexuality, HIV
Robert Garofalo, MD, MPH, is the Division Head of Adolescent Medicine at Ann & Robert H. Lurie Children’s Hospital of Chicago and a Professor of Pediatrics at Northwestern University Feinberg School of Medicine. He is a Co-Director of Lurie Children’s Gender and Sex Development Program, the first comprehensive program for gender nonconforming children and adolescents in the Midwest. Dr. Garofalo also directs Lurie Children’s Adolescent/Young Adult HIV Program and the Center for Gender, Sexuality and HIV Prevention, which conducts research on topics in adolescent sexual health, gender, sexuality, HIV prevention and health disparities affecting adolescent and young adult populations at risk of acquiring HIV. He is a national expert on lesbian, gay, bisexual and transgender (LGBT) health issues in youth, as well as adolescent sexuality and HIV clinical care and prevention. Dr. Garofalo is the former President of the Gay and Lesbian Medical Association. In 2010, he served as a committee member for the National Academy of Sciences/Institute of Medicine Committee on Lesbian, Gay, Bisexual and Transgender Health Issues and Research Gaps and Opportunities.
genetics and addiction, Animal Behavior, Animal Models, Drug Treatment, Binge Drinking, Risk Factors, alcohol withdrawal; , Reward, Aversion, Taste, selective breedig
I have been working at the VA Medical Center and in the Department of Behavioral Neuroscience at the Oregon Health & Science University in Portland since 1979. I entered graduate school at the University of Colorado to obtain a Ph.D. in social psychology. Fortuitously, I was sidetracked into instead studying behavioral neuroscience (AKA biopsychology) at the fledgling Institute for Behavioral Genetics in Boulder. I’ve been pretty much surrounded by mice ever since. I did post-doctoral work at the University of Wisconsin- Milwaukee and was a Lecturer in Psychology at San José State and then UC-Santa Barbara, and then held a two-year research position at a Dutch pharmaceutical company in the Dutch hinterlands before Portland. My research interest is in understanding individual differences in behavioral susceptibility to alcohol and other drugs of abuse, and their genetic and neurobiological bases. Most recently, I’ve been breeding mice that voluntarily drink alcohol until they become intoxicated, i.e. developing a mouse model of university students. I’m working with collaborators to figure out how many genes we’ve affected in the process, which ones they are, and what their biological functions are. We’re using that information to try to predict some drugs that are already FDA approved that might be re-purposed to try as treatments for alcoholism. My expertise is in mouse behavioral tests that try to capture human traits such as anxiety, sensitivity to drug’s rewarding or aversive effects, incoordination, learning and memory, novelty-seeking, and so forth. I am less fluent in rat than in mouse but the languages are related. I am familiar with psychiatric genetics/human genetics methods, but not really expert in the more esoteric of them. I am also familiar with the big data/genomics/informatics approaches, but again not really expert there, either.
---
Dr. Lara Ray received her PhD in Clinical Psychology from the University of Colorado at Boulder. During her graduate degree she completed interdisciplinary training in behavioral genetics and neuroscience. Dr. Ray completed a predoctoral clinical internship at Brown University Medical School where she stayed for a postdoctoral fellowship at the Brown University Center for Alcohol and Addiction Studies. After her postdoctoral fellowship, Dr. Ray joined the faculty at the UCLA Clinical Psychology Program where she is now a Full Professor. Dr. Ray also has academic appointments in the UCLA Department of Psychiatry and Human Behavior and the UCLA Brain Research Institute. Dr. Ray has an active program of research on clinical neuroscience of addiction. Her laboratory combines experimental psychopharmacology with behavioral genetic and neuroimaging methods to ascertain the mechanisms underlying addictive disorders in humans and applying these insights to treatment development. Dr. Ray has over 150 peer-reviewed publications and book chapters. Her program of research is funded by the National Institute on Alcohol and Abuse and Alcoholism (NIAAA) as well as the National Institute on Drug Abuse (NIDA). Dr. Ray’s current interest centers around the clinical science informed translation of neurobiological models of addiction to clinical samples. Dr. Ray has received awards from the American Psychological Association (APA) for early career contributions to the science of addiction, including awards from the Society of Addiction Psychology (APA div 50), the Society of Clinical Psychology (APA div 12), and the Research Society for Alcoholism.
Alcohol, HIV, TBI, metabolic alterations , Muscle, Inflamation
Patricia E. Molina, MD, PhD, is the Richard Ashman Professor and Head of Physiology, and Director of the Alcohol and Drug Abuse Center at LSU Health Sciences Center New Orleans’ School of Medicine. Dr. Molina's training as a physician prior to completing training in physiology provides her with a unique systems approach to study the biomedical consequences of chronic heavy alcohol use, with emphasis on the pathophysiological mechanisms that aggravate HIV disease progression. Her research focuses on the interaction of chronic alcohol consumption on progression of HIV disease in preclinical models and in translational studies. Her research involves integrating in vivo with ex vivo approaches to understand the contribution of organ systems to disease pathogenesis. Another area of research interest and ongoing investigations is the interaction of alcohol with outcomes from traumatic brain injury. Her work examines the mechanisms that lead to greater alcohol drinking during the post-injury phase, and the potential role of the endocannabinoid system in modulating those responses. Dr. Molina is interested in translating research findings to the community at large, and in educating the lay public on the consequences of excessive alcohol consumption. This is particularly relevant to young students and parents as they make decisions on alcohol drinking throughout their life.
Please enter your username and
password to login
close
-
News keyboard_arrow_right
Latest News Coronavirus News Currently Embargoed News Research News Releases Google Fact Check Research Alert Preprints Marketplace News with Video/Audio Multimedia
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right